Tag Archives: Canada

BEST (Biotechnology Entrepreneurship Student Team) 2011 INDIA sponsored By DBT

HOW IT WORKS?

A nationwide ‘Call for Proposals’ in the area of life sciences that has commercialization potential will be announced through various communication media.

Students have to form a team comprising of 5 team members, identify a team leader and a faculty member/mentor as a Guide. The Guide is optional.

Each team will submit a Concept Note based on which a Panel will screen the applications and shortlist 20 teams. These 20 teams will attend a fully paid for high quality Entrepreneurship Workshop that will familiarize them on matters related to starting a business venture like Business Plans, IP & Patenting Strategies, Raising Finance, Business Strategies and HR Practices. At the end of the Workshop, each team will develop a business plan based on their Concept and learning from the Workshop and make a ten minute power point presentation to the Jury. The Jury will evaluate and critique each of the business plans and identify 3 winning teams.

The 3 Winning teams will be awarded Prize money of Rs.500, 000/-, Rs. 300,000/- and Rs. 200,000/ respectively.

The winning teams will be also be given an opportunity to attend and present their business plans at ABLE’s Annual BioInvest Conference. BioInvest is ABLE’s flagship conference that brings together on one platform Life Science Companies, Institutional Investors and Investment Bankers to explore opportunities for investment.

“KINARM” A VIRTUAL REALITY ARM

A virtual-reality technology invented in Canada could improve how health workers assess people suffering from brain injuries and brain diseases.

The KINARM combines a chair with robotic arms and a virtual-reality system that allows researchers to guide patients through tasks, such as hitting balls with virtual paddles.

Once the tests are done, the system gives a detailed report on how the patient differed from normal.

The system has several advantages over traditional testing methods, such as touching one’s finger or nose, said Prof. Stephen Scott of the Centre for Neuroscience Studies at Queen’s University in Kingston, Ont.

“No. 1 is that it is objective,” Scott said Monday from San Diego, where he is the presenting the research at the Society for Neuroscience Conference.

Currently, clinicians often assess patients with brain injuries and disease using crude, subjective scoring systems that range from zero to two, based on whether the patient can touch a nose or another object.

But those systems offer few choices, which makes to difficult to identify problems and show improvements after therapy, Scott said.